{"id":"W2057194480","doi":"10.3747/co.v16i4.469","title":"The Role of her2-Targeted Therapies in Women with her2-Overexpressing Metastatic Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Santé Montérégie; Cancer Care Nova Scotia; Hôpital du Saint-Sacrement; Ottawa Hospital; Health Sciences Centre; University of Alberta; University of Toronto; Université de Sherbrooke; Centre hospitalier universitaire de Québec; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; University of Ottawa","funders":"","keywords":"Trastuzumab; Medicine; Metastatic breast cancer; Oncology; Breast cancer; Internal medicine; Targeted therapy; Pertuzumab; Clinical trial; Adjuvant; Cancer; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005210486,0.0001533484,0.0004363895,0.0001121507,0.00007012972,0.00001601861,0.0001969384,0.00005703726,0.0003403625],"category_scores_gemma":[0.0000514073,0.000092079,0.0000366037,0.0003568768,0.0002780703,0.00005540644,0.00003533034,0.0004469652,0.000006607472],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007163963,"about_ca_system_score_gemma":0.0008192503,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002028381,"about_ca_topic_score_gemma":0.0002395561,"domain_scores_codex":[0.9982633,0.0002542036,0.0003192493,0.0002443093,0.0003770264,0.0005419312],"domain_scores_gemma":[0.9990599,0.0002101426,0.0001336227,0.0002972652,0.000169291,0.0001297509],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002117057,0.0007588785,0.04287796,0.00009333024,0.00009658786,0.00002229227,0.004090226,0.00002319495,0.006841204,0.0001426594,0.0007569649,0.9421796],"study_design_scores_gemma":[0.006525837,0.003742034,0.6056721,0.001261639,0.00008573334,0.0001397814,0.008170228,0.0006275213,0.004162762,0.002816969,0.3664627,0.000332674],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9684013,0.02341297,0.00001655286,0.005527881,0.0001993412,0.0005938559,0.00002884078,0.00002798657,0.001791288],"genre_scores_gemma":[0.9972112,0.002039815,0.0001735424,0.000178456,0.0001230548,0.0001785575,0.000003540315,0.00001910725,0.0000727429],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.941847,"threshold_uncertainty_score":0.3754872,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07348489514262137,"score_gpt":0.4417653748954514,"score_spread":0.3682804797528301,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}